Showing results (41-50 of 92) with videos related to
Sort By:
Pageof 10
Journal of Clinical Pathology|February 5, 2017
Ticagrelor reversal: in vitro assessment of four haemostatic agentsLeyla Calmette, Anne-Céline Martin, Bernard Le Bonniec, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|October 18, 2024
Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical PointsIsabelle Gouin-Thibault, Alexandre Mansour, Michael Hardy, et al.Annales De Biologie Clinique|June 11, 2011
[Hodgkin lymphoma in the elderly]Tiphaine Belleville, Samir Bouhadiba, Juliette Fontaine, et al.Journal of Thrombosis and Haemostasis : JTH|May 20, 2026
How to monitor and manage unfractionated heparin in practice (Part 1): Guidance from the SSC of the ISTHIsabelle Gouin-Thibault, Corinne Frere, Lana A Castellucci, et al.Annales De Biologie Clinique|December 5, 2012
Anemia in the elderly: usefulness of an easy and comprehensive laboratory screenEric Pautas, Virginie Siguret, Thi Mai Anh Kim, et al.International Journal of Laboratory Hematology|September 14, 2023
Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC-MS for plasma level dabigatran quantification: Results from DRIVING studyAmbre de Fautereau-Vassel, Antoine Mokhtarian, Manon Mangenot, et al.Annales De Biologie Clinique|October 7, 2020
[Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?]Michael Hardy, Jonathan Douxfils, Jean-Michel Dogné, et al.Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|June 22, 2011
[Divisibility of warfarin and fluindione tablets tested in elderly patients and their family circle]Eric Pautas, Jérémie Despres, Isabelle Peyron, et al.Anaesthesia, Critical Care & Pain Medicine|October 21, 2021
GFHT proposals on the practical use of argatroban - With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)Virginie Siguret, Elodie Boissier, Emmanuel De Maistre, et al.Thrombosis and Haemostasis|March 13, 2015
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxabanGeorges Jourdi, Virginie Siguret, Anne Céline Martin, et al.Pageof 10